Literature DB >> 8222265

Erythrocyte galactokinase assay with high performance liquid chromatography.

N Mizoguchi1, T Eguchi, N Sakura, K Ueda.   

Abstract

An assay for erythtocyte galactokinase based on high performance liquid chromatographic determination of galactose 1-phosphate (Gal-1-P) is described. The determination of Gal-1-P was applied to a post-column fluorometric detection of reducing sugars using arginine. This method is as sensitive and accurate as conventional radioisotopic methods, but needs no radioisotopic facilities. It requires only a small blood sample and is suitable as a follow-up test in neonatal screening.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222265     DOI: 10.1016/0009-8981(93)90147-v

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Congenital porto-left renal venous shunt as a cause of galactosaemia.

Authors:  N Mizoguchi; N Sakura; H Ono; K Naito; M Hamakawa
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

2.  Improvement of galactose uptake in Saccharomyces cerevisiae through overexpression of phosphoglucomutase: example of transcript analysis as a tool in inverse metabolic engineering.

Authors:  Christoffer Bro; Steen Knudsen; Birgitte Regenberg; Lisbeth Olsson; Jens Nielsen
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

3.  Ultra fast and sensitive liquid chromatography tandem mass spectrometry based assay for galactose-1-phosphate uridylyltransferase and galactokinase deficiencies.

Authors:  Yijun Li; Adam S Ptolemy; Lauren Harmonay; Mark Kellogg; Gerard T Berry
Journal:  Mol Genet Metab       Date:  2010-09-21       Impact factor: 4.797

4.  Differential diagnosis of neonatal mild hypergalactosaemia detected by mass screening: clinical significance of portal vein imaging.

Authors:  Y Nishimura; G Tajima; A Dwi Bahagia; A Sakamoto; H Ono; N Sakura; K Naito; M Hamakawa; C Yoshii; M Kubota; K Kobayashi; T Saheki
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.